“Honest And Straightforward” 483 Responses May Avert Warning Letters
CDER is weighing companies' responses to FDA-483 inspection reports in considering whether to issue warning letters, Center for Drug Evaluation & Research Office of Compliance Director David Horowitz said
You may also be interested in...
FDA's dispute resolution draft guidance will allow manufacturers 10 days to challenge FDA inspection findings
FDA expects to release a draft on improving the agency's good manufacturing practices management systems by Dec. 1
FDA expects to issue a draft guidance in the coming months on a formal dispute resolution process for scientific and technical issues that arise during inspections